2003 Adult Asthma Data: Prevalence Tables and Maps

Next Table

Table L1
Adult Self-Reported Lifetime Asthma Prevalence Rate (Percent) and
Prevalence (Number) by State or Territory: BRFSS 2003
State Sample
Size
Prevalence
(percent)
Standard
Error
95% CI*
(percent)
Prevalence
(number)
95% CI*
(number)
U.S. Total** 257,312 11.9 0.12 (11.6 – 12.1) 25,777,202 (25,253,228 – 26,301,175)
AL 3,339 11.6 0.69 (10.2 – 12.9) 391,671 (344,755 – 438,586)
AK 2,658 13.3 0.94 (11.4 – 15.1) 60,933 (52,350 – 69,515)
AZ 3,233 12.5 0.85 (10.8 – 14.1) 511,360 (442,669 – 580,051)
AR 4,199 11.3 0.57 (10.2 – 12.5) 231,481 (208,429 – 254,533)
CA 4,475 13.4 0.61 (12.2 – 14.6) 3,473,157 (3,159,980 – 3,786,335)
CO 4,064 12.4 0.62 (11.2 – 13.6) 424,685 (382,048 – 467,321)
CT 5,310 12.2 0.51 (11.2 – 13.2) 319,497 (292,831 – 346,164)
DE 4,038 11.7 0.67 (10.4 – 13.1) 72,281 (64,193 – 80,370)
DC 2,038 12.7 0.92 (10.9 – 14.5) 58,117 (49,709 – 66,525)
FL 5,034 10.1 0.64 (8.8 – 11.4) 1,327,772 (1,160,520 – 1,495,023)
GA 7,633 11.8 0.58 (10.7 – 13.0) 757,493 (682,252 – 832,733)
HI 4,332 11.6 0.61 (10.4 – 12.8) 110,997 (99,397 – 122,597)
ID 4,992 11.7 0.55 (10.6 – 12.8) 114,347 (103,705 – 124,990)
IL 5,264 11.1 0.49 (10.2 – 12.1) 1,046,454 (955,243 – 1,137,665)
IN 5,474 12.0 0.49 (11.0 – 13.0) 552,962 (507,863 – 598,062)
IA 4,999 10.3 0.56 (9.2 – 11.3) 227,881 (203,092 – 252,669)
KS 4,613 11.5 0.58 (10.4 – 12.7) 232,690 (209,131 – 256,250)
KY 7,622 12.6 0.58 (11.4 – 13.7) 391,927 (355,888 – 427,966)
LA 5,072 10.2 0.51 (9.2 – 11.2) 336,420 (303,080 – 369,760)
ME 2,384 13.4 0.81 (11.8 – 15.0) 134,498 (118,149 – 150,847)
MD 4,433 12.3 0.66 (11.0 – 13.6) 507,830 (453,073 – 562,588)
MA 7,569 14.4 0.53 (13.3 – 15.4) 710,328 (657,631 – 763,025)
MI 3,546 13.6 0.68 (12.2 – 14.9) 1,019,132 (917,708 – 1,120,556)
MN 3,874 10.5 0.60 (9.4 – 11.7) 395,216 (350,313 – 440,120)
MS 4,416 10.9 0.57 (9.8 – 12.0) 230,890 (206,877 – 254,903)
MO 4,250 11.9 0.71 (10.5 – 13.3) 508,330 (447,777 – 568,883)
MT 4,018 11.1 0.67 (9.7 – 12.4) 76,242 (67,137 – 85,348)
NE 4,970 10.3 0.51 (9.3 – 11.3) 132,872 (119,889 – 145,856)
NV 2,969 11.4 0.82 (9.8 – 13.0) 189,390 (162,510 – 216,270)
NH 5,036 12.9 0.57 (11.8 – 14.0) 125,421 (114,329 – 136,514)
NJ 11,293 10.9 0.36 (10.2 – 11.6) 710,625 (663,057 – 758,193)
NM 5,490 10.5 0.49 (9.5 – 11.4) 142,570 (129,244 – 155,895)
NY 5,535 11.7 0.51 (10.7 – 12.7) 1,697,945 (1,552,265 – 1,843,625)
NC 9,446 11.3 0.52 (10.3 – 12.3) 720,819 (654,489 – 787,149)
ND 3,021 10.1 0.62 (8.9 – 11.3) 48,224 (42,385 – 54,062)
OH 3,821 10.8 0.64 (9.6 – 12.1) 931,899 (822,170 – 1,041,629)
OK 7,624 11.8 0.46 (10.9 – 12.7) 309,038 (284,965 – 333,111)
OR 4,010 14.7 0.63 (13.4 – 15.9) 395,124 (361,248 – 428,999)
PA 3,665 11.9 0.62 (10.7 – 13.1) 1,129,529 (1,013,649 – 1,245,408)
RI 4,042 14.4 0.69 (13.0 – 15.7) 118,314 (106,840 – 129,788)
SC 5,921 10.1 0.47 (9.2 – 11.1) 316,653 (287,245 – 346,060)
SD 5,257 10.7 0.57 (9.6 – 11.8) 60,240 (53,705 – 66,775)
TN 2,586 11.8 0.80 (10.3 – 13.4) 523,609 (451,749 – 595,469)
TX 6,022 11.3 0.49 (10.3 – 12.2) 1,791,427 (1,635,135 – 1,947,720)
UT 4,048 11.3 0.69 (9.9 – 12.6) 180,462 (158,370 – 202,553)
VT 4,243 12.2 0.60 (11.0 – 13.4) 57,969 (52,187 – 63,750)
VA 5,435 12.1 0.61 (10.9 – 13.3) 676,348 (609,102 – 743,593)
WA 18,605 13.8 0.33 (13.2 – 14.5) 634,069 (604,438 – 663,700)
WV 3,346 11.8 0.62 (10.6 – 13.0) 166,795 (149,482 – 184,107)
WI 4,049 11.0 0.62 (9.8 – 12.2) 451,051 (399,911 – 502,190)
WY 3,999 11.2 0.57 (10.1 – 12.4) 42,219 (37,967 – 46,471)
Territories
GU 805 10.3 1.15 (8.1 – 12.6) 10,922 (8,533 – 13,311)
PR 4,166 20.7 0.85 (19.0 – 22.3) 581,761 (532,656 – 630,865)
VI 2,051 9.2 0.96 (7.3 – 11.1) 6,783 (5,343 – 8,223)

Next Table
Notes:

* CI denotes confidence interval.

** U.S. Total includes the 50 states plus the District of Columbia and excludes the three territories.

If values for the standard error and the 95% confidence interval are not provided, the normal approximation to the binomial distribution does not apply due to small sample size.

When the sample size is less than 50, estimates are not precise and should be interpreted with caution.

View Page In: PDF [167K]